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Franc¸ois-Neetens fleck corneal dystrophy (CFD) is a rare, autosomal dominant corneal dystrophy characterized by
numerous small white flecks scattered in all layers of the stroma. Linkage analysis localized CFD to a 24-cM (18-
Mb) interval of chromosome 2q35 flanked by D2S2289 and D2S126 and containing PIP5K3. PIP5K3 is a member
of the phosphoinositide 3-kinase family and regulates the sorting and traffic of peripheral endosomes that contain
lysosomally directed fluid phase cargo, by controlling the morphogenesis and function of multivesicular bodies.
Sequencing analysis disclosed missense, frameshift, and/or protein-truncating mutations in 8 of 10 families with
CFD that were studied, including 2256delA, 2274delCT, 2709CrT (R851X), 3120CrT (Q988X), IVS19-1GrC,
3246GrT (E1030X), 3270CrT (R1038X), and 3466ArG (K1103R). The histological and clinical characteristics
of patients with CFD are consistent with biochemical studies of PIP5K3 that indicate a role in endosomal sorting.
Introduction
Franc¸ois-Neetens fleck corneal dystrophy (CFD [MIM
121850]) is an autosomal dominant corneal dystrophy
characterized by numerous small white flecks scattered
in all layers of the stroma. Franc¸ois and Neetens de-
scribed this disorder for the first time in 1957, calling it
“he´re´dodystrophie mouchete´e” (Franc¸ois and Neetens
1957). Typically, the stroma in between the flecks is clear,
and the endothelium, epithelium, Bowman layer, and
Descemet membrane are normal. Except for an occa-
sional patient with minor photophobia, patients are usu-
ally asymptomatic and have normal vision; the disease
is most often found at routine examination. The corneal
flecks appear to not progress significantly throughout
life (Patten et al. 1976; Akova et al. 1994). In vivo con-
focal microscopy examination has made the clinical
diagnosis more straightforward, with CFD evident by
small bright deposits around keratocyte nuclei through-
out the stroma.
The flecks in CFD may appear as early as at 2 years
of age or even at birth, but generally they are reported
Received March 7, 2005; accepted for publication April 25, 2005;
electronically published May 18, 2005.
Address for correspondence and reprints: Dr. Daniel F. Schorderet,
Institut de Recherche en Ophtalmologie, Avenue du Grand-Champ sec
64, 1950 Sion, Switzerland. E-mail: daniel.schorderet@iro.vsnet.ch
* These two authors contributed equally to this work.
 2005 by The American Society of Human Genetics. All rights reserved.
0002-9297/2005/7701-0006$15.00
not to progress significantly throughout life. However,
individual 15 in family 50003 showed no signs of CFD
on slit-lamp examination at age 2 years, but, at age 6
years, it was observed that two stromal lesions in the
left eye and one in the right eye had developed (Jiao et
al. 2003). Although CFD is thought to be rare, speci-
fic incidence figures are difficult to obtain. It has been
suggested that, because of its subtle presentation, CFD
might be much more common than has been appreci-
ated in the literature (Streeten and Falls 1961; Birndorf
and Ginsberg 1972; Patten et al. 1976; Goldberg et al.
1977).
On histological examination, the corneal flecks ap-
pear to correspond to abnormal keratocytes swollen
with membrane-limited intracytoplasmic vesicles con-
taining complex lipids and acid mucopolysaccharides.
There are no extracellular abnormalities (Nicholson et
al. 1977; Purcell et al. 1977), and laboratory screening
has shown no systemic metabolic abnormalities (Patten
et al. 1976). Thus, it was thought that this dystrophy
might represent a dominantly inherited metabolic dis-
order confined to the cornea (Nicholson et al. 1977).
CFD was previously mapped to a 27.9-cM region of
chromosome 2q35 flanked by D2S117 and D2S126,
with the highest LOD scores shown at D2S2289
( ; ), D2S325 ( ; ),Z p 4.46 vp 0 Z p 3.28 vp 0max max
D2S317 ( ; ), D2S143 ( ;Z p 3.1 v p 0 Z p 3.8max max
), and D2S2382 ( ; ). Multi-vp 0.03 Z p 5.0 vp 0max
point analysis confirmed linkage to the region between
D2S117 and D2S126, with a maximum multipoint
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Table 1
PCR Primers for 41 Exons and cDNA of PIP5K3
The table is available in its entirety in the online edition
of The American Journal of Human Genetics.
Table 2
Conditions for DHPLC of PIP5K3 Exons
The table is available in its entirety in the online edition
of The American Journal of Human Genetics.
LOD score of 5.0 located midway between D2S2289
and D2S325. Analysis of CFD in the same families with
the assumption of 90% penetrance increased the max-
imum LOD score to 6.28 at D2S157 (Jiao et al. 2003).
The present study was performed with 10 families,
including the original 4 families studied by Jiao et al.
(2003), and refined the linked region to a 24-cM inter-
val flanked by D2S2289 and D2S126 and containing
∼18 Mb. Sequencing of numerous candidate genes in
this region in affected members from 8 of 10 families
showed mutations in PIP5K3, which encodes a widely
expressed 2,089-aa phosphoinositide 3-kinase family
member active in post-Golgi vesicular sorting.
Material and Methods
Patients and Clinical Findings
Ten unrelated families of European origin that contain
69 individuals, including 32 affected individuals, 27 un-
affected individuals, and 10 unaffected spouses, were
enrolled in this study. Families 50001 and 50007 are
of mixed European origin (American), family 50002 is
of Italian origin, family 50004 is of Yugoslavian origin,
and the remaining families are of Swiss origin. Control
individuals were of mixed European origin (from the
United States, Italy, and Switzerland). The diagnosis of
CFD was based on the presence of typical small white
flecks throughout the corneal stroma. Both affected and
unaffected family members underwent a complete oph-
thalmological examination. In affected individuals, the
corneal epithelium and endothelial layer showed no ab-
normalities. The corneal stroma showed the presence of
typical hyperreflective dots throughout but was other-
wise normal. Confocal microscopy findings for family
5005 also showed hyperreflective inclusions associated
with the basal nerves (Frueh and Bohnke 1999). Detailed
ocular, medical, and family histories were obtained for
each available family member. This project was ap-
proved by the institutional review board of the National
Eye Institute and by the Ethics Committee of the Faculty
of Medicine, University of Lausanne. The patients ad-
mitted to this study gave their informed consent, and
the study adhered to the tenets of the Declaration of
Helsinki.
Genotyping and Linkage Analyses
DNA was extracted either directly from blood or from
transformed lymphoblastoid cell lines, by use of stan-
dard phenol-chloroform protocols (Smith et al. 1989).
Two-point linkage analysis was performed using the
FASTLINK version (Schaffer et al. 1994) of MLINK
from the LINKAGE program package (Lathrop and
Lalouel 1984; Cottingham et al. 1993). Maximum LOD
scores were calculated using ILINK. CFD was initially
analyzed as a fully penetrant, autosomal dominant trait.
The gene frequency of CFD was set at 0.0001, and an
equal allele frequency was used for all markers.
Candidate-Gene Analysis
Candidate genes were chosen in the 24-cM CFD-
linked interval flanked by D2S2289 and D2S126 on
chromosome 2q35, estimated to contain 1300 genes or
potential genes. To confirm that the candidate genes are
expressed in the human cornea, human corneal total
RNA was extracted with an RNeasy Fibrous Tissue Mini
kit (QIAGEN), corneal cDNA was made using RT-PCR
with the use of SuperScriptTM III First-Strand Synthesis
System (Invitrogen), and direct PCR amplification of the
cDNA was performed. Expression of PIP5K3 was tested
by PCR analysis of corneal cDNA with the use of exon
1 forward and exon 3 reverse primers (table 1).
Denaturing High-Pressure Liquid Chromatography
(DHPLC) and Sequence Analysis
Coding exons and adjacent intronic sequences of
PIP5K3 were amplified from genomic DNA by use of
the primers shown in table 1. PCR amplification of
each of the 41 exons was performed in 20-ml reactions
involving 2.5 U of AmpliTaq Gold (ABI), 2 ml of
10# AmpliTaq Gold Buffer, 1.9 mM MgCl2, 0.25 mM
dNTPs, 0.25 mM of primers, and 40 g of genomic DNA.
PCR cycling conditions consisted of an initial 10-min
denaturation step at 95C for 5 min; 32 cycles at 94C
for 40 s, 55C for 30 s (61C for exon 19b), and 72C
for 40 s; and a final elongation step at 72C for 7 min.
PCR products were screened by DHPLC on a WAVE
system (Transgenomics). Buffer A contained 0.1 M tri-
ethylammonium acetate (TEAA [Transgenomics]). Buf-
fer B contained 0.1 M TEAA and 25% acetonitrile,
HPLC grade (Sigma-Aldrich). The flow rate was set at
0.9 ml/min, and the buffer B gradient increased by 2%
per min for 4 min. The optimum temperature was de-
termined for each DNA fragment by Wavemaker soft-
ware (Transgenomics). When multiple melting domains
were established, each domain was analyzed at the ap-
propriate temperature. Initial buffer B concentrations
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Figure 1 Slit-lamp image (A) and confocal microscopy image (B) of the cornea in a patient with CFD
and temperatures for each fragment are listed in table 2.
PCR products were purified using Millipore Montage
PCRm96 plates or QIAquick PCR purification kits. The
PCR templates were sequenced using ABI Dye Termi-
nator, version 1 or 3, in a final reaction volume of 10
ml. Products of the sequencing reactions were purified
using the Edge Biosystems Performa TM DTR gel-fil-
tration system and were run on a 3100 ABI genetic
analyzer. Sequences were aligned using the Seqman
program of the DNASTAR package (DNASTAR) or
Chromas, version 2.23 (Technelysium). The reference
genomic sequence is available from NCBI (accession
number NM_015040).
Protein Analysis
Structural motifs of the lipoprotein lipid attachment
site were localized in the phosphatidylinositol-4-phos-
phate 5-kinase type III sequence (PIP5K3) by use of
PROSITE. The search for spectrin sequence repeats was
performed using rapid automatic detection and align-
ment of repeats (RADAR), and a search for structural
motifs was performed using the simple modular archi-
tecture research tool (SMART), the Superfamily 1.65
HMM library and genome assignment service, the NIH
homology alert service Whales, and the protein families
database (PFAM) (see Web Resources). Sequence align-
ment was performed using the GCG-Lite ClustalW
1.74 multiple sequence alignment program (see Web
Resources).
The chaperone-like domain structure of PIP5K3 was
derived by homology modeling, with the crystal coor-
dinates of protein database (PDB) file 1a6d as the struc-
tural template (Abola et al. 1987). For each model,
amino acid sequences were aligned using the method of
Needleman and Wunsch (1970). The three-dimensional
structure was built using the program Look, version
3.5.2 (Lee and Subbiah 1991; Lee 1994), followed by
500 cycles of nonbound energy minimization. The con-
formation of mutant proteins was refined by 500 cycles
of self-consistent ensemble optimization (Lee 1994). The
geometry of the predicted structures was tested with the
Procheck program (Laskowski et al. 1993).
Results
Patient Ascertainment
Individuals were diagnosed as affected on the basis of
the typical appearance of corneal flecks on slit-lamp ex-
amination and, in some individuals, in vivo confocal
microscopy (fig. 1). Of the 10 families investigated here,
4 (families 50001, 50002, 50003, and 50004) were pre-
viously studied by Jiao et al. (2003) and are described
more fully in that study. Additional individuals and fam-
ilies 50005, 50006, 50008, 50009, and 50010 showed
classical CFD and were asymptomatic, whereas affected
individuals from family 50007 showed photophobia,
which was severe enough in individual 5 (see pedigree
in fig. 2) to result in blepharospasm and facial spasm,
requiring multiple botulinum toxin injections to control
the spasms. Family 50005 and one affected individual
from family 50006 were reported elsewhere (Frueh and
Bohnke 1999).
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Figure 3 Sequence analysis for representative affected individuals from families with CFD. HTZ p heterozygous.
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Table 3
Two-Point Linkage Results for Markers in the CFD Region of Chromosome 2q35
MARKER
POSITION LOD SCORE AT v p
Zmax ˆvcM Mb 0 .01 .05 0.1 .02 .03 .04
D2S364 192.90 182.86  1.32 1.14 1.89 2.05 1.57 .82 2.05 .2
D2S117 201.40 195.44  3.90 1.22 .21 .48 .53 .30 .53 .3
D2S311 203.10 197.39  1.75 2.87 3.04 2.60 1.75 .75 3 .07
D2S2289 205.40 203.49  4.42 4.74 4.53 3.66 2.48 1.16 4.7 .03
D2S325 210.90 208.10 4.64 4.60 4.36 3.99 3.11 2.08 .98 4.64 0
D2S157 212.60 211.03 1.32 1.55 1.91 2.00 1.79 1.31 .69 2 .1
D2S317 215.10 213.33 3.67 3.61 3.38 3.05 2.29 1.45 .63 3.67 0
D2S143 217.00 214.70  3.87 4.83 4.82 4.02 2.75 1.25 4.83 .05
D2S2382 220.70 216.87  5.01 5.25 4.94 3.90 2.57 1.12 5.27 .3
D2S2249 223.10 218.54  4.18 4.51 4.30 3.46 2.34 1.06 4.54 .04
D2S2359 225.60 220.77  1.16 .49 1.05 1.18 .85 .40 1.18 .2
D2S126 228.80 221.84  1.75 1.26 2.13 2.26 1.65 .77 2.26 .2
D2S396 240.20 230.51  6.20 2.25 .79 .20 .32 .12 .32 .3
Linkage Analysis
Two-point linkage analysis suggested that the CFD
locus is linked to a 12-cM region flanked by D2S2289
and D2S143 (table 3). This region includes markers
D2S325 ( ; ) and D2S317 (Z p 4.64 v p 0 Z pmax max
; ). Significant LOD scores were also seen3.67 vp 0
with other markers in the region, including D2S2289
( ; ), D2S143 ( ;Z p 4.7 v p 0.03 Z p 4.83 vpmax max
), D2S2382 ( ; ), and D2S22490.05 Z p 5.27 vp 0.3max
( ; ), although these markers showedZ p 4.54 vp 0.04max
obligate recombinants.
Haplotype analysis confirmed the critical interval (fig.
2). A recombination event in affected individual 7 of
family 50007 set the centromeric boundary at D2S2289,
and other centromeric obligate recombination events
took place between D2S117 and D2S311 in individual
10 of family 50001, individual 16 of family 50003, and
individual 7 of family 50004. Telomeric obligate re-
combination events took place between D2S126 and
D2S396 in affected individuals 12 and 16 of family
50003, and the recombination in affected individual 14
of family 50003 set the telomeric boundary at D2S126.
In addition, unaffected individual 9 of family 50001
showed a recombination event at D2S2359, and unaf-
fected individual 7 of family 50001 showed an obli-
gate recombination at D2S143. Thus, the CFD locus is
linked to chromosome 2 between D2S2289 and D2S126,
and—on the basis of recombination events in unaffected
individuals in whom the gene might not, in fact, be pen-
etrant—the locus is probably between D2S2289 and
D2S143. In family 50003, unaffected individuals 3 and
18 share part of the risk haplotype, although individuals
1, 2, and 4 (through whom individuals 3 and 18 are
connected to the affected individuals in this family) were
not available for genotyping and examination.
DHPLC and Mutation Analysis
The interval contains PIP5K3, which has 41 coding
exons spanning 189 kb and encodes a 2,098-aa protein.
PCR amplification and DHPLC, followed by direct se-
quencing of the putative exons and intron-exon bound-
aries, showed mutations in 8 of 10 families studied (fig.
3). Mutations were confirmed in all available affected
family members.
Screening of exon 16 revealed two significant sequence
variations. Family 50001 showed mutation 2256delA,
which causes a shift of the reading frame and the gen-
eration of an early stop codon after 6 aa, removing the
final 1,392 aa. Family 50004 showed 2274delCT, which
also causes a shift of the ORF and an early truncation
after 5 aa. Five other families exhibit mutations in exon
19. Nonsense mutation 2962CrT (Q988X) was ob-
served in family 50003; 2709CrT (R851X) in family
50005; 3246GrT (E1030X) in family 50008; and
3270CrT (R1038X) in family 50009. Family 50010
displays the only missense mutation observed to date.
Nucleotide A at position 3466 was mutated to G, chang-
ing the lysine codon at position 1103 to arginine. In
family 50007, the splice-acceptor site of exon 20 shows
an IVS19-1 GrC transversion. This is predicted to cause
skipping of exon 20, with a resultant frame shift and
an early truncation after 10 additional amino acids. All
these mutations were observed in a heterozygous state
and were not observed in 100 control individuals (200
control individuals for mutation K1103R) of similar
(European) ethnic background. In two families, 50002
and 50006, the complete screening of the coding regions
of PIP5K3 revealed neither point mutations nor small
insertions and deletions. In family 50002, a single base
insertion (IVS15-82insA) was observed in intron 15, as
well as the 13-bp deletion IVS1511r24. Both these
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Figure 4 Schematic diagram of PIP5K3, showing the locations and effect of the dominant mutations. A, Domain structure of PIP5K3.
FYVE represents the FYVE zinc-finger domain; DEP represents the Disheveled, EGL-10, plextrin homology domain; Cpn60-TCP1 represents
the chaperone-like Cpn-60-TCP1 domain; SPEC represents the two spectrin repeats; and PIPKc represents the domain with phosphatidylinositol-
4-phosphate 5-kinase activity. Red arrows show the positions of the truncation mutations associated with CFD, and the blue arrow shows the
missense mutation K1103R. B, Molecular structure of the Cpn60-TCP1 domain of PIP5K3, as predicted by homology modeling with the
thermosome structure (PDB: 1a6d) as a structural template. The a helices (cylinders) and b strands (ribbons) are shown. C, Effect of dominant
mutations in position 711 or 705 on the structure of the Cpn60-TCP1 domain.
sequence variants are observed in control individuals in
a homozygous state and are not considered pathogenic.
PIP5K3 Molecular Organization
A schematic diagram of the PIP5K3 protein structure
is shown in figure 4A. Homology to several structural
fragments from the PDB was found. First, homology to
a zinc finger–containing phosphoinositide kinase (FYVE
[PDB: 1dvp]) is located at positions 150–219 (E value
p 5.9e18), with eight cysteines, at positions 160, 164,
167, 180, 183, 188, 191, and 192, that are potentially
able to coordinate two zinc atoms. Second, a structural
motif shows similarity to a DEP domain (Disheveled,
EGL-10, plextrin homology domains of ∼70 aa that are
present in numerous signaling proteins [PDB: 1fsh]) of
unknown function found in secreted proteins (positions
365–440; E value p 8.3e27). A search with Super-
family 1.65 localizes a cytosolic chaperone CCTg apical
domain–like motif (PDB: 1gml) at position 677 through
843 of the PIP5K3 protein (E value p 1.3e27), with
a sequence identity of 29.8% and a similarity of 58.5%.
The 1791–2085 region of the last C-terminal fragment
is similar to that of the common kinase core found in
the type IIb phosphatidylinositol-4-phosphate 5-kinase
(PDB: 1bo1) (Rao et al. 1998). The location of these
four motifs agrees with that published previously (Shish-
eva et al. 2001). In addition, a small b-sheet “winged
helix” DNA/RNA–binding motif at positions 348–489
(E value p 3.8e18) and two spectrin repeats at po-
sitions 1490–1538 and 1679–1729 were found. Spec-
trin repeats form a three-helix bundle (PDB: 1quu) and
are found in several proteins involved in cytoskeletal
structure.
A search using the SMART method shows homology
to the archaeal chaperonin thermosome structure (PDB:
1a6d), with an E value of 7.0e14. The sequence of
this protein is 36% identical to the CCTg apical domain
(Ditzel et al. 1998), containing ∼170 overlapping resi-
dues. ClustalW 1.74 sequence alignment of the ther-
mosome 1a6d and PIP5K3 (residues 462–1026) se-
quences have shown 20.2% identity and 50% similarity,
suggesting that the structure of thermosome is suitable
for use as a template for building an atomic model of
this sequence fragment. The model of the three-dimen-
sional structure of the domain similar to Cpn60-TCP1
was obtained using the thermosome 1a6d structure, as
shown in figure 4B.
CFD nonsense mutations interrupt the PIP4K3 protein
sequence at positions 705, 711, 951, 988, 1030, 1038,
and 1217. All these mutations affect the C-terminal part
of the PIP5K3 sequence, eliminating both the spectrin
repeats and the PIPKc sequence. In addition, the two
mutations at positions 705 and 711 remove almost half
of the C-terminal domain (fig. 4C), destroying the polar
surface of the central cavity of the protein domain pos-
sibly involved in protein folding (Ditzel et al. 1998), and
are predicted to eliminate the chaperone-like domain of
the protein.
Discussion
The CFD locus has been mapped in five unrelated fam-
ilies of European origin to a 24-cM (18-Mb) region of
chromosome 2q35 flanked by D2S2289 and D2S126,
and CFD has been associated with mutations in PIP5K3,
a protein which is important for post-Golgi vesicle pro-
cessing. Mutations were identified in 8 of 10 families in
the present study. All but one of these are protein-trun-
cating mutations, predicted to cause termination of the
peptide chain before the PIP5K3 structure is formed and
to result in loss of activity.
No mutation was identified in family 50002 or
50006. Affected individuals in both of these families
have typical CFD and could not be differentiated clin-
ically from affected individuals from other families in
the study. Although family 50006 is small and was not
included in the linkage study, family 50002 is linked to
the PIP5K3 region, with a LOD score of 1.74, which
is consistent with involvement of PIP5K3 or a nearby
gene, although unaffected individual 3 also inherited
the risk haplotype specific for this family. This suggests,
but does not prove, that affected individuals in family
50002 may have an intronic or noncoding regulatory
mutation that has not yet been identified. Although
these will be further investigated as additional families
are studied, identification of noncoding mutations can
be difficult and may require functional studies of splic-
ing or promoter activity.
A K1103R missense mutation was observed in fam-
ily 50010. Since most mutations reported here are non-
sense mutations, the causative role of this variant may
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be questionable. Several lines of evidence suggest that
K1103R is a mutation. This variant segregated in all
affected individuals and was not observed in 1400 con-
trol chromosomes. A search of dbSNP indicated a total
of 15 SNPs in the coding region of PIP5K3, 8 of which
are nonsynonymous. Position 1103 is not among them.
In addition, K1103 is conserved in various species as
divergent as mouse, Xenopus, and Fugu. Confirmation
of the causative role of this mutation awaits functional
assays or studies of additional families with the same
base change.
PIP5K3, a large gene comprising 41 exons that span
189 kb, encodes a predicted 2,098-aa protein. The
PIP5K3 protein is a member of the phosphoinositide 3-
kinase family, which comprises dual-specificity enzymes
possessing an intrinsic protein kinase activity insepa-
rable from a lipid kinase activity. These can generate
and relay protein phosphorylation signals to regulate
the formation and intracellular location of lipid prod-
ucts (Sbrissa et al. 2000). Both maintenance of mam-
malian cell morphology and endocytic membrane ho-
meostasis require enzymatically active phosphoinosi-
tide 5-kinase PIKfyve (Ikonomov et al. 2001; Shisheva
et al. 2001). Cultured mammalian cells transiently trans-
fected with a kinase-deficient point mutant, PIKfyve
K1831E, show dilation of PIKfyve-containing vesicles
and progressive accumulation of multiple swollen lucent
endosomal vacuoles, initially in the perinuclear cy-
toplasm and later in the cell periphery. This indicates
that active PIKfyve enzyme must be present in a distinct
set of late endocytic membranes for normal cell mor-
phology (Ikonomov et al. 2001). The formation of
enormously dilated late endocytic structures upon trans-
fection of enzymatically inactive PIKfyve suggests a role
for PIP5K3 in the endosome-to-trans-Golgi network
(Ikonomov et al. 2003b).
It has been suggested that PIP5K3 selectively regulates
the sorting and traffic of peripheral endosomes con-
taining lysosomally directed fluid phase cargo by con-
trolling the morphogenesis and function of multives-
icular bodies (Ikonomov et al. 2003a). This role is
entirely consistent with the clinical and histological find-
ings for CFD, in which the corneal flecks appear to be
abnormally swollen keratocytes with membrane-limited
intracytoplasmic vacuoles containing complex lipids
and glycosaminoglycans (Nicholson et al. 1977). Al-
though the clinical findings for CFD are confined to the
cornea, only limited studies of other tissues have been
done, and the presence of a subset of abnormal cells in
most tissues might not result in clinical symptoms.
In summary, the present study describes both the
mapping of the CFD locus in 10 unrelated families of
European origin to a 24-cM (18-Mb) region of chro-
mosome 2q35 flanked by D2S2289 and D2S126 and
the association of CFD with mutations in the PIP5K3
protein, which is important for post-Golgi vesicle pro-
cessing. Mutations were identified in 8 of 10 families
studied. All but one of these mutations are predicted to
result in truncation of the PIP5K3 protein before the
protein structure is formed, resulting in the loss of ac-
tivity. Enzymatic studies of the PIP5K3 enzyme in af-
fected individuals should further elucidate the role of
this enzyme in CFD and in normal cellular metabolism.
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Web Resources
The accession number and URLs for data presented herein
are as follows:
GCG-Lite ClustalW 1.74 multiple sequence alignment pro-
gram, http://www.ebi.ac.uk/clustalw/
NCBI, http://www.ncbi.nlm.nih.gov/ (for reference genomic se-
quence [accession number NM_015040])
Online Mendelian Inheritance in Man (OMIM), http://www
.ncbi.nlm.nih.gov/Omim/ (for CFD)
PFAM, http://www.sanger.ac.uk/Software/Pfam/
ScanProsite, tool to search the PROSITE database, http://
us.expasy.org/tools/scanprosite/
RADAR, http://www.ebi.ac.uk/Radar/
SMART at European Laboratory of Molecular Biology, http:
//smart.embl-heidelberg.de/
Superfamily 1.65, HMM library and genome assignment ser-
vice, http://supfam.mrc-lmb.cam.ac.uk/
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